< Zurück zu den aktuellen Neuigkeiten & Events

Veranstaltungen

Challenging granted patents: a comparison between Europe and the US

Oktober 2021

Veranstaltungsdatum: 3. November 2021

HGF and Knobbe Martens are holding a webinar on 3rd November.

Challenging granted patents: a comparison between Europe and the US

In this webinar we will compare and contrast mechanisms for challenging patents in both Europe and the US. In particular, we will focus on opposition proceedings before the European Patent Office (EPO) along with proceedings at the Patent Trial and Appeal Board (PTAB) in the US. Comparisons will be made between each of the jurisdictions illustrated by case studies as examples. Additionally, the panel will provide practical tips on how to maximize the chance of success in each jurisdiction.

This webinar will cover:

  • An outline of the European opposition process and PTAB trials process in the US generally, including inter partes review (IPR) and post-grant review (PGR)
  • Tactical considerations and approach prior to filing an opposition in Europe or a petition for IPR/PGR in the US
  • Discussion of key differences between European and the US invalidity proceedings
  • Practice updates from Europe, including the use of videoconferencing for oral proceedings and changes to the Rules of Procedure at the Boards of Appeal
  • Practice updates from the US, including discretionary denials and the many challenges to the NHK-Fintiv rule, which may block IPRs when co-pending litigation exists
  • Strategy considerations in deciding whether to challenge a U.S. patent versus a European patent.
Speakers

Aktuelle Neuigkeiten

Agritech Thymes: Die Gefahr der stillschweigenden Zustimmung: Lehren aus dem Fall „Pink Lady“

Kann die Lieferung einer Pflanzensorte ohne klare und definierte Nutzungsbeschränkungen als stillschweigende Zustimmung zu ihrer Vermarktung angesehen werden? Im Mittelpunkt dieses Falls stehen die Beweise, die erforderlich sind, um „ernsthafte …

Weiterlesen

IAM Global Leaders 2026

HGF is proud to announce that we have 3 partners listed as an IAM Global Leader 2026. To qualify for inclusion in the IAM Global Leaders, individuals must be ranked …

Weiterlesen

The Bite of Implied Consent: Lessons from the Pink Lady Case

A recent European Union court decision considers the issue of implied consent to commercialise a plant variety, and whether the evidence meets the threshold of “serious doubts” of the validity …

Weiterlesen
Event - 5. November 2025

HGF ist Gold-Sponsor von IAM Live: Navigating the UPC 2025

Wir freuen uns, Ihnen mitteilen zu können, dass HGF Gold-Sponsor von IAM Live: Navigating the UPC 2025 ist, das am 5. November im Marriott Opera Ambassador Hotel in Paris stattfindet. …

Veranstaltungsdetails

HGF ranked band 1 in Chambers and Partners UK 2026

The Chambers and Partners UK 2026 Guide is now live and HGF has one again been highly ranked as a firm, with several recognised individuals across multiple regions. HGF is …

Weiterlesen

How France's investment in digital health, AI, and bioinformatics is transforming the intellectual property (IP) landscape

In recent years, France has become a key player in digital health innovation, driven by strategic government investments under the France 2030 initiative and the French Tech 2030 program. These …

Weiterlesen
Event - 14. Oktober 2025

The Future of Protein Production Amsterdam 2025

HGF are proud to be sponsoring the Future of Protein Production Amsterdam 2025, the leading global event bringing together innovators across fermentation, cultivated and plant-based proteins. Date: 29-30th October 2025  …

Veranstaltungsdetails

Ein Wendepunkt für die Patentierbarkeit von KI?

Direktor Squires hebt PTAB § 101-Ablehnung im Fall DeepMind auf In einer bemerkenswerten frühen Maßnahme als Unterstaatssekretär für Handel und Direktor des USPTO hat John Squires eine Entscheidung des Patent …

Weiterlesen